Functional characterization of Jurkat T cells rescued from CD95/Fas-induced apoptosis through the inhibition of caspases

Biochemical and Biophysical Research Communications

Volumn 270, Issue 3, 2000, Pages 1009-1015

  Ko, S C W ^a   Johnson, V L ^a   Chow, S C ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE; FAS ANTIGEN; PHYTOHEMAGGLUTININ; TRIPEPTIDE;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME INHIBITION; HALF LIFE TIME; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0034696785     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.2565     Document Type: Article

References (29)

1. Thompson C. B. Apoptosis and the pathogenesis and treatment of disease. Science. 267:1995;1456-1462.
2. Reed J. C. Cellular mechanisms of disease series. J. Cell Biol. 124:1994;1-6.
3. Cohen G. M. Caspases: The executioners of apoptosis. Biochem. J. 326:1997;1-16.
4. Nicholson D. W., Thornberry N. A. Caspases: Killer proteases. TIBS. 22:1997;299-306.
5. Nicholson D. W. ICE/CED3-like proteases as therapeutic targets for the control of inappropriate apoptosis. Nature Biotech. 14:1996;297-301.
6. Thornberry N. A., Rano T. A., Peterson E. P., Rasper D. M., Timkey T., Garcia-Calvo M., Houtzager V. M., Nordstrom P. A., Roy S., Vaillancourt J. P., Chapman K. T., Nicholson D. W. A combinatorial approach defines specificities of members of the caspase family and granzyme B: Functional relationships established for key mediators of apoptosis. J. Biol. Chem. 272:1997;17907-17911.
7. Chow S. C., Weis M., Kass G. E. N., Holmström T. H., Eriksson J. E., Orrenius S. Involvement of multiple proteases during Fas-mediated apoptosis in T lymphocytes. FEBS Lett. 364:1995;134-138.
8. Jacobson M. D., Weil M., Raff M. C. Role of CED-3/ICE-family proteases in staurosporine-induced programmed cell death. J. Cell Biol. 133:1996;1041-1051.
9. Slee E. A., Zhu H., Chow S. C., MacFarlane M., Nicholson D. W., Cohen G. M. Benzyloxycarbonyl-val-ala-asp (OMe) fluoromethylketone (z-VAD-FMK) inhibits apoptosis by blocking the processing of CPP32. Biochem. J. 315:1996;21-24.
10. Medema J. P., Scaffidi C., Kischkel F. C., Shevchenko A., Mann M., Krammer P. H., Peter M. E. Flice is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J. 16:1997;2794-2804.
11. Rodriguez I., Matsuura K., Ody C., Nagata S., Vassalli P. Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death. J. Exp. Med. 184:1996;2067-2072.
12. Friedlander R. M., Brown R. H., Gagliardini V., Wang J., Yuan J. Inhibition of ICE slows ALS in mice. Nature. 388:1997;31.
13. Longthorne V. L., Williams G. T. Caspase activity is required for commitment to Fas-mediated apoptosis. EMBO J. 16:1997;3805-3812.
14. Johnson V. L., Cooper I. R., Jenkins J. R., Chow S. C. Effects of differential overexpression of Bcl-2 on apoptosis, proliferation and teleomerase activity in Jurkat T cells. Exp. Cell Res. 252:1999;175-184.
15. Scaffidi C., Medema J. P., Krammer P. H., Peter M. E. FLICE is predominantly expressed as two functionally active isoforms, caspase-8/α and caspase-8/β J. Biol. Chem. 272:1997;26953-26958.
16. Dhein J., Walczak H., Bäumier C., Debatin K.-M., Krammer P. H. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature. 373:1995;438-441.
17. Martinez-Lorenzo M. J., Alava M. A., Anel A., Pineiro A., Naval J. Release of preformed Fas ligand in soluble form is the major factor for activation-induced death of Jurkat cells. Immunol. 89:1996;511-517.
18. Muzio M., Chinnaiyan A. M., Kischkel F. C., Orourke K., Shevchenko A., Ni J., Scaffidi C., Bretz J. D., Zhang M., Gentz R., Mann M., Krammer P. H., Peter M. E., Dixit V. M. Flice, a novel Fadd-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/Apo-1) death-inducing signaling complex. Cell. 85:1996;817-827.
19. Boldin M. P., Goncharov T. M., Goltsev Y. V., Wallach D. Involvement of Mach, a novel Mort1/Fadd-interacting protease, in Fas/APO-1 and TNF receptor-induced cell death. Cell. 85:1996;803-815.
20. Hirata H., Takahashi A., Kobayashi S., Yonehara S., Sawai H., Okazaki T., Yamamoto K., Sasada M. Caspase are activated in a branch protease cascade and control distinct downstream process in Fas-induced apoptosis. J. Exp. Med. 187:1998;587-600.
21. Squier M. K. T., Cohen J. J. Calpain and cell death. Cell Death Different. 3:1996;275-283.
22. Schreiber S. L., Crabtree G. R. The mechanism of action of cyclosporin A and FK506. Immunol. Today. 13:1992;136-142.
23. Izquierdo Pastor M., Reif K., Cantrell D. The regulation and function of p21(ras) during T-cell activation and growth. Immunol. Today. 16:1995;159-164.
24. Clipstone N. A., Crabtree G. R. Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature. 357:1992;695-697.
25. Weiss A., Iwashima M., Irving B., Van Oers N. S. C., Kadlecek T. A., Straus D., Chan A. Molecular and genetic insights into T cell antigen receptor signal transduction. Adv. Exp. Med. Biol. 65:1994;53-62.
26. Xiang J., Chao D. T., Korsmeyer S. J. Bax-induced cell death may not require interleukin 1beta-converting enzyme-like proteases. Proc. Natl. Acad. Sci. USA. 93:1996;14559-14563.
27. McCarthy N. J., Whyte M. K. B., Gilbert C. S., Evan G. I. Inhibition of CED-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl-2 homologue Bak. J. Cell Biol. 136:1997;215-227.
28. Miossec C., Dutilleul V., Fassy F., Diu-Hercend A. Evidence for CPP32 activation in the absence of apoptosis during T lymphocyte stimulation. J. Biol. Chem. 272:1997;13459-13462.
29. Vercammen D., Brouckaert G., Denecker G., Van der Craen M., Declerq W., Fiers W., Vandenbeele P. Dual signaling of the Fas receptor: Initiator of both apoptotic and necrotic cell death pathways. J. Exp. Med. 188:1998;919-930.